Interleukine 6 as a Predictor of Outcome in Mechanically Ventilated Patients With Covid 19
Serum Interleukine 6 as a Predictor of Outcome in Mechanically Ventilated Patients With Covid 19
1 other identifier
observational
50
1 country
1
Brief Summary
Serum IL-6 levels will be determined by enzyme-linked immunosorbent assay according to the manufacturer's instructions and the normal range is \<10 pg/mL , Patients' medical records will be carefully reviewed and analyzed. Patient data regarding demographics, comorbidities, signs and symptoms, laboratory results and complications will be collected. The occurrence of complications will be confirmed according to the following criteria: acute respiratory distress syndrome (ARDS) defined according to the Berlin definition
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2022
CompletedFirst Submitted
Initial submission to the registry
March 9, 2022
CompletedFirst Posted
Study publicly available on registry
March 10, 2022
CompletedMarch 10, 2022
February 1, 2022
6 months
March 9, 2022
March 9, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
detection of acute respiratory distress syndrome
hypoxia, incresed plateau pressure
2 weeks
Eligibility Criteria
patients more than 20 years old, covid positive, mechanically ventilated
You may qualify if:
- Age: more than 20 years.
- Gender: both males and females will be included.
- Mechanically Ventilated patients.
- COVID 19 confirmed diagnosis
You may not qualify if:
- Immunocompromised patients.
- Oxygen saturation more than 95% without ventilation.
- Malignancy.
- Patients refuse to be enrolled in the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Sohag Universitylead
Study Sites (1)
Sohag University, Faculty of Medicine
Sohag, Egypt
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Target Duration
- 6 Months
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- lecturer of anesthesia and intensive care
Study Record Dates
First Submitted
March 9, 2022
First Posted
March 10, 2022
Study Start
June 1, 2021
Primary Completion
December 1, 2021
Study Completion
January 1, 2022
Last Updated
March 10, 2022
Record last verified: 2022-02